CA2179341A1 - Methodes pour isoler, enrichir des cultures cellulaires, et accelerer leur maturation - Google Patents

Methodes pour isoler, enrichir des cultures cellulaires, et accelerer leur maturation

Info

Publication number
CA2179341A1
CA2179341A1 CA002179341A CA2179341A CA2179341A1 CA 2179341 A1 CA2179341 A1 CA 2179341A1 CA 002179341 A CA002179341 A CA 002179341A CA 2179341 A CA2179341 A CA 2179341A CA 2179341 A1 CA2179341 A1 CA 2179341A1
Authority
CA
Canada
Prior art keywords
cells
cell
serum
agent
vitro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002179341A
Other languages
English (en)
Inventor
Gregory S. Korbutt
Ray V. Rajotte
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2179341A1 publication Critical patent/CA2179341A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0676—Pancreatic cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0676—Pancreatic cells
    • C12N5/0677—Three-dimensional culture, tissue culture or organ culture; Encapsulated cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/126—Immunoprotecting barriers, e.g. jackets, diffusion chambers
    • A61K2035/128—Immunoprotecting barriers, e.g. jackets, diffusion chambers capsules, e.g. microcapsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/24—Genital tract cells, non-germinal cells from gonads
    • C12N2502/246—Cells of the male genital tract, non-germinal testis cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CA002179341A 1996-04-12 1996-06-18 Methodes pour isoler, enrichir des cultures cellulaires, et accelerer leur maturation Abandoned CA2179341A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US1531096P 1996-04-12 1996-04-12
US60/015,310 1996-04-12
US1973796P 1996-06-14 1996-06-14
US60/019,737 1996-06-14

Publications (1)

Publication Number Publication Date
CA2179341A1 true CA2179341A1 (fr) 1997-10-13

Family

ID=26687221

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002179341A Abandoned CA2179341A1 (fr) 1996-04-12 1996-06-18 Methodes pour isoler, enrichir des cultures cellulaires, et accelerer leur maturation

Country Status (4)

Country Link
EP (1) EP0894127A2 (fr)
AU (1) AU2283497A (fr)
CA (1) CA2179341A1 (fr)
WO (1) WO1997039107A2 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6352707B1 (en) 1992-02-24 2002-03-05 Anton-Lewis Usala Transplant encapsulation in a hydrogel matrix to obscure immune recognition
US6231881B1 (en) 1992-02-24 2001-05-15 Anton-Lewis Usala Medium and matrix for long-term proliferation of cells
DE60115433T2 (de) 2000-05-31 2006-08-03 Encelle, Inc. Verfahren zur behandlung von chronischen geschwüren
WO2002032437A1 (fr) * 2000-10-17 2002-04-25 Diatranz Limited Preparation et xenogreffe d'ilots porcins
WO2003027270A1 (fr) * 2001-09-28 2003-04-03 Diabcell Pty Limited Croissance d'une matiere pour xenotransplant dans une culture
CA2884852A1 (fr) * 2011-09-28 2013-04-04 Islet Sciences, Inc. Maturation ex vivo de cellules d'ilots pancreatiques
KR101914837B1 (ko) * 2016-12-08 2018-11-02 서울대학교산학협력단 신생돼지의 췌도 분리 방법
CN115197890A (zh) * 2022-06-02 2022-10-18 成都中科奥格生物科技有限公司 一种胰岛细胞培养基及其制备方法和用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1196862A (fr) * 1983-06-01 1985-11-19 Anthony M.F. Sun Microencapsulement de cellules et de tissus vivants
EP0127989A3 (fr) * 1983-06-01 1986-03-26 Connaught Laboratories Limited Micro-encapsulation de tissu vivant et de cellules
EP0363125A3 (fr) * 1988-10-03 1990-08-16 Hana Biologics Inc. Produit contenant des cellules pancréatiques endocrines aptes à proliférer et procédé
US5227298A (en) * 1990-08-17 1993-07-13 The Trustees Of Columbia University In The City Of New York Method for microencapuslation of cells or tissue
US5578314A (en) * 1992-05-29 1996-11-26 The Regents Of The University Of California Multiple layer alginate coatings of biological tissue for transplantation
ATE221575T1 (de) * 1993-05-10 2002-08-15 Univ Michigan Gentransfer zu den pankreatischen epithelzellen
US5849285A (en) * 1994-04-13 1998-12-15 Research Corporation Technologies, Inc. Autoimmune disease treatment with sertoli cells and in vitro co-culture of mammal cells with sertoli cells
WO1997016536A1 (fr) * 1995-10-30 1997-05-09 Vivorx, Inc. Procede permettant une proliferation et une differentiation ex vivo de cellules des ilots pancreatiques adultes, milieux utiles pour ce procede et leurs utilisations

Also Published As

Publication number Publication date
WO1997039107A2 (fr) 1997-10-23
WO1997039107A3 (fr) 1997-12-11
AU2283497A (en) 1997-11-07
EP0894127A2 (fr) 1999-02-03

Similar Documents

Publication Publication Date Title
Korbutt et al. Large scale isolation, growth, and function of porcine neonatal islet cells.
ES2276392T3 (es) Crecimiento in vitro de islotes funcionales de langerhans y utilizaciones in vivo de los mismos.
Zimmermann et al. Hydrogel-based non-autologous cell and tissue therapy
US6149907A (en) Treatments using sertoli cells
Lee et al. Cell transplantation for endocrine disorders
WO1996040178A1 (fr) Utilisation d'ilots et de cellules de sertoli localises conjointement dans des transplants cellulaires d'heterogreffe
KR19990067077A (ko) 기능성 랑게르한스 섬의 시험관내 성장 및 그 생체내 사용방법
AU780366B2 (en) Preparation and xenotransplantation of porcine islets
NO320713B1 (no) Farmasoytisk preparat som omfatter Sertoli-celler og celler som produserer en biologisk faktor, seksjonert sett med beholdere for cellene, produktartikkel som omfatter et embaleringsmateriale med Sertoli-celler og fremgangsmate for okning av utvinning og profilering av celler ex vivo.
Akolpoglu et al. Recent advances in the design of implantable insulin secreting heterocellular islet organoids
JPH11514877A (ja) 機能性ランゲルハンス島のインビトロ成長およびそのインビボの使用
Luca et al. Accelerated functional maturation of isolated neonatal porcine cell clusters: in vitro and in vivo results in NOD mice
CA2179341A1 (fr) Methodes pour isoler, enrichir des cultures cellulaires, et accelerer leur maturation
EP1438395B1 (fr) Croissance d'une matiere pour xenotransplant dans une culture
Schrezenmeir et al. Long-term function of porcine islets and single cells embedded in barium-alginate matrix
Prokop Bioartificial pancreas: materials, devices, function, and limitations
JP2022017474A (ja) １型糖尿病治療用Ｓｉ－ＨＰＭＣカプセル化インスリン産生細胞
US20030068308A1 (en) Intrasplenic encapsulated cell therapy
CA2693382C (fr) Cellules souches fusionnees utilisees dans le traitement du diabete et methodes associees
Sambanis Engineering challenges in the development of an encapsulated cell system for treatment of type 1 diabetes
Han et al. Preparation of microencapsulated VEGF gene-modified human umbilical cord mesenchymal stem cells and in vitro culture.
JPH06508762A (ja) 卵黄嚢幹細胞
AU2002334485B2 (en) Growing xenotransplant material in culture
Brendel et al. Cellular transplantation and gene therapy
RU2152800C1 (ru) Способ культивирования и модификации гетерогенных клеток млекопитающих

Legal Events

Date Code Title Description
FZDE Dead